NeuroOne Brasil

NeuroOne Brasil operates across neurotechnology, digital health, and education, with an offering that connects EEG measurement to neurofeedback and progress tracking. Its described applications span school-based attention training and professionally supervised clinical use, including a 12-week PACE program delivered remotely with single-channel EEG. This combination gives the company a cross-setting profile rather than a clearly documented focus on only consumer wellness, education software, or clinical equipment. Its stated technology includes real-time brain-signal reading, neuroadaptive games, and longitudinal metrics, which distinguish the offering at the product-description level. No comparable companies are identified in the available profile, so naming specific competitors or asserting a relative advantage would be unsupported. The company’s competitive position therefore remains difficult to benchmark. Its clearest point of differentiation is the stated effort to combine measurement, training, and progress visibility across educational and professional contexts, rather than any verified market lead.

There are no confirmed funding rounds, funding amounts, valuation figures, employee counts, hiring updates, or dated product launches in this profile. Consequently, it is not possible to identify a financing or hiring inflection point or quantify expansion over time. The company’s described product scope does show several connected elements: a NeuroOne EEG device, single-channel brain-signal measurement, neurofeedback training, neuroadaptive games, and progress tracking. The PACE program is described as a remotely delivered, professionally supervised 12-week offering, while other applications address attention training in schools and clinical use by health professionals. This breadth suggests an approach spanning hardware, training, and use-case-specific services, but it does not by itself demonstrate commercial growth or adoption. The trajectory should therefore be treated as unverified: the product concept and target settings are identifiable, while the timing, pace, and commercial results of development remain unknown.